In addition, combined administration of the dual mTOR/DNA-PK Inhibitor CC-115 and radiotherapy has been shown to inhibit tumor growth and significantly reduce the migration rate in HNSCC cell lines [236]. This evidence concerns the gene PRKDC and head and neck squamous cell carcinoma.